Navigation Links
Europe leads the world in assisted-reproduction technology
Date:6/29/2010

Rome, Italy: Europe leads the world in Assisted Reproduction Technology (ART) with most cycles initiated in the region, the 26th Annual Meeting of the European Society of Human Reproduction and Embryology heard today (Wednesday 30 June).

According to data presented by the European IVF Monitoring Group (EIM), 479,288 treatment cycles were reported in 32 European countries in 2007 . This compares globally with 142,435 cycles from the US and 56,817 cycles from Australia and New Zealand. "The number of cycles performed in many developed countries has grown by 5-10% per annum over the last 5 years," said Dr. Jacques de Mouzon, chairman of ESHRE's EIM. "The 4.5% increase we observed in Europe from 2006 to 2007 however is partly due to more clinics reporting to our database," he added.

In 28 countries where clinics reported deliveries, more than 90,000 babies were born in 2007. There were 118,667 regular IVF treatments, 246,687 intracytoplasmic sperm injection (ICSI) cycles, 74,855 frozen embryo transfer cycles (FER), 15,028 egg donor cycles (ED), 6,822 preimplantation genetic diagnosis/screening cycles (PGD/PGS) and 660 in vitro maturation cycles (IVM). "The reverse trend from IVF to ICSI continues with now 67.5% of fresh cycles using the latter technology, although the efficacy of ICSI in terms of pregnancy rates is the same as standard IVF," he added.

He pointed out that the overall rate of multiple births was very similar to the previous year with European ART twin deliveries at 20.5% and triplet deliveries at 0.8%. Most countries in Europe are now recording fewer than 1% triplet deliveries, except for Italy (2.8%), Latvia (11.1%) and Serbia (3.3%). "The good news is that since 1997, we have observed a decline from 30% to 21% in overall multiple birth rates and a fourfold reduction in triplet deliveries from 3.7% to 0.8%," he said.

Nordic countries like Denmark still have the highest availability of ART at 13,263 cycles per mill
'/>"/>

Contact: Hanna Hanssen
hanna@eshre.eu
European Society of Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Emergo Group Acquires UK-based Mediqol Ltd.; Greatly Expands Medical Device Consulting Presence in Europe
2. European Cancer Organization supports a revision of the EU Clinical Trials Directive
3. In Europe, Most Men Can Trace Roots to Near East Migrants
4. An invitation to Europes largest forum on breast cancer
5. New Health Report Exposes Imminent Risk of a Stroke Crisis in Europe
6. Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
7. Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)
8. Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan
9. The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center
10. Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan
11. Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 On Saturday, September 27, 2014, La ... and fitness fair ¡Vive tu vida! Get Up! Get Moving!® ... for better health and wellness for people of all ages ... to the public, will be held at Anson B. Nixon ... to 2:00 pm. , “This is a wonderful event ...
(Date:9/22/2014)... The invitation only Summit held ... 60 industry executives and thought leaders from major ... Retro Fitness, and Xsport Fitness. Also in attendance ... marketing agencies and private equity investors representing over ... , The Summit highlighted best practices for solving ...
(Date:9/22/2014)... HealthDay Reporter FRIDAY, Sept. 19, ... with type 2 diabetes found that intensively lowering blood ... strokes and deaths. But intensive blood sugar control didn,t ... study, investigators followed nearly 8,500 participants of a completed ... and blood sugar levels strictly controlled, while others had ...
(Date:9/22/2014)... 2014 The Advocator Group, LLC— The ... partnership with the RxCut® pharmacy savings program, which will ... employees. The company looks forward to offering prescription savings ... ways in which they deliver on the goal to ... Free For All® Inc., the RxCut® pharmacy ...
(Date:9/22/2014)... At the 10th Clinton Global ... Partnership (SNP) announced the successful launch of a ... Risk Reduction Program for Women. The announcement of ... their risk of heart disease through a seafood-rich ... for addressing significant global challenges made by CGI ...
Breaking Medicine News(10 mins):Health News:La Comunidad Hispana Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:La Comunidad Hispana Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Motionsoft Concludes Inaugural 2014 Technology Summit 2Health News:Motionsoft Concludes Inaugural 2014 Technology Summit 3Health News:Tight Blood Sugar Control Doesn't Prevent Strokes in Diabetics: Study 2Health News:Tight Blood Sugar Control Doesn't Prevent Strokes in Diabetics: Study 3Health News:The Advocator Group, LLC Announces Partnership with Pharmacy Savings Program RxCut® 2Health News:The Advocator Group, LLC Announces Partnership with Pharmacy Savings Program RxCut® 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 4
... Reporter , TUESDAY, Sept. 14 (HealthDay News) -- An expert ... and Fosamax can actually raise risks for a rare type ... the U.S. Food and Drug Administration -- which has been ... that effect on the drugs, labeling. "Bisphosphonates may be ...
... Maryland, September 14, 2010 Neuralstem, Inc. (NYSE ... cells survived in rat brains affected by stroke ... showed significant improvement in some motor skill and ... Adherent Human Neural Stem Cells To Reverse Motor ...
... can positively affect the human brain function, according to ... research, which was published in the journal NeuroImage ... environment impacts upon our brain functions. The ... such as the sea, cause distinct brain areas to ...
... with muscular dystrophy die 10 to 12 years younger than ... 14 issue of Neurology , the medical journal of ... which was calculated on the basis of 20 years of ... of research into racial disparities in health care, say Dr. ...
... medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) ... behavior changes that affect many childhood cancer survivors, ... Jude Children,s Research Hospital investigators. Researchers reported ... young cancer survivors scored better on tests of ...
... Amanda Gardner HealthDay Reporter , MONDAY, Sept. 13 ... ask an expert panel later this week whether or not ... heart risks. In documents released Monday ahead of the ... of its Endocrinologic & Metabolic Drugs Advisory Committee will be ...
Cached Medicine News:Health News:Expert Panel Links Popular Bone Drugs to Rare Fracture 2Health News:Expert Panel Links Popular Bone Drugs to Rare Fracture 3Health News:Neuralstem stem cells survive and differentiate into neurons in rats with stroke 2Health News:Study shows tranquil scenes have positive impact on brain 2Health News:Blacks with muscular dystrophy die 10-12 years younger than whites: New study 2Health News:Childhood cancer survivors show sustained benefit from common ADHD medication 2Health News:Childhood cancer survivors show sustained benefit from common ADHD medication 3Health News:FDA Panel to Mull Ban on Diet Drug Meridia 2Health News:FDA Panel to Mull Ban on Diet Drug Meridia 3
(Date:9/22/2014)... 2014 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products, is pleased to announce that ... signed a definitive lease agreement for a second facility ... facility has 28,966 square feet of floor space with ... mezzanine space for a total of approximately 43,500 square ...
(Date:9/22/2014)... PLYMOUTH MEETING, Pa. , Sept. 22, 2014 ... ) announced today it has initiated a phase ... The trial will evaluate the safety, tolerability, and ... type 6 (HPV-6), which causes most aerodigestive cancers. ... tongue, nose, throat, vocal cords, and parts of ...
(Date:9/22/2014)... YORK , Sept. 22, 2014 ... exclusive, global license agreement with Plasma Technologies LLC ... proprietary plasma fractionation process. Concurrently, the Company announced ... to strategically refocus and rebrand the company as ... a national listing for its common shares. ...
Breaking Medicine Technology:T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6
... Feb. 18, 2011 Replacing both knees in one ... was associated with significantly fewer prosthetic joint infections as ... after surgery, compared with total knee replacements performed in ... a moderately higher risk of adverse cardiovascular outcomes within ...
... 18, 2011 Novavax, Inc. (Nasdaq: NVAX) ... final safety and immunogenicity results from its 2009 H1N1 ... Mexico at the invitation-only 7th World Health Organization Meeting ... Trials. The meeting was held at the WHO headquarters ...
Cached Medicine Technology:Two Knee Replacements May Be Better Than One 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 3NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 4NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 5
... November 2005. Specifications, including colors, subject to ... lb (2.3 kg), FreeStyle by AirSep is ... for those patients who know no boundaries. ... FreeStyle captures the heart of what it ...
... is AirSep Corporations most economical line of ... lpm of therapeutic oxygen in home, hospital, ... of units in daily use throughout the ... known for high performance, easy maintenance, and ...
... to 10 LPM of oxygen reducing the delivery ... M10 is engineered to reduce the cost of ... fewer parts than any other concentrator on the ... you to reduce expenditure on accessories and unnecessary ...
... conserver, it's important to have a choice that ... name synonymous with innovative excellence, offers two great ... automatic and value packed conservers., ,With its ... used 8 hours a day for 3 to ...
Medicine Products: